Risk Factors for Arteriovenous Fistula Thrombus Development: A Systematic Review and Meta-Analysis

Abstract

<b><i>Background:</i></b> Risk factors like female sex, fistula location, hypertension, albumin, diabetes, arteriovenous graft (AVG), age, and other factors are related to arteriovenous fistula thrombus (AVFT), but the consistency and magnitude of their associations have not been confirmed by meta-analysis. <b><i>Objectives:</i></b> The purpose of this study was to provide a comprehensive and up-to-date synthesis of evidence on the association between potential risk factors and AVFT. <b><i>Methods:</i></b> In this systematic review and meta-analysis, PubMed, Embase, Cochrane Library, and Web of Science databases were searched for articles published up to April 20th, 2022, and cohort, cross-sectional, and case-control studies examining the association (odds ratio [OR]) between potential risk factors and AVFT were identified. The other inclusion criteria were sufficient data for analysis and nonoverlapping datasets, excluding reviews, meta-analyses, and articles with overlapping datasets. Extracted variables included first author, publication year, study type, sample size, percentage of women, vascular access type, risk or protective factors, and measure of association (adjusted estimates of effect of all risk factors). The study protocol is registered at PROSPERO (CRD42020201884) and followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. <b><i>Results:</i></b> Among the 27 identified studies, data from 24 cohort, 2 case-control, and 1 cross-sectional study were included in this review. When compared to non-AVFT, our data showed that the significant risk factors were AVG (pooled OR = 6.28, 95% CI = 1.79–22.02, <i>p</i> = 0.004, <i>I</i><sup>2</sup> = 87%), age (pooled OR = 1.06, 95% CI = 1.00–1.13, <i>p</i> = 0.05, <i>I</i><sup>2</sup> = 98%), female sex (pooled OR = 2.62, 95% CI = 2.56–2.69, <i>p</i> < 0.00001, <i>I</i><sup>2</sup> = 0%), C-reactive protein (pooled OR = 1.18, 95% CI = 1.08–1.30, <i>p</i> = 0.0005, <i>I</i><sup>2</sup> = 90%), fistula site (distal) (pooled OR = 3.64, 95% CI = 1.74–7.62, <i>p</i> = 0.0006, <i>I</i><sup>2</sup> = 47%), hypertension (pooled OR = 1.21, 95% CI = 1.00–1.47, <i>p</i> = 0.05, <i>I</i><sup>2</sup> = 46%), CD34<sup>+</sup>KDR<sup>+</sup> cell (pooled OR = 1.85, 95% CI = 1.33–2.57, <i>p</i> = 0.0002, <i>I</i><sup>2</sup> = 0%), and eprex use (pooled OR = 5.36, 95% CI = 1.82–15.77, <i>p</i> = 0.002, <i>I</i><sup>2</sup> = 0%). <b><i>Conclusions:</i></b> The meta-analysis suggests that AVG, age, female sex, CRP level, fistula site (distal), hypertension, CD34<sup>+</sup>KDR<sup>+</sup> cell, and the use of eprex are independent risk factors for AVFT. Therefore, clinical medical staff should treat these risk factors carefully, identify them early, and prevent them early to reduce the occurrence of AVFT.

Comparative analysis of RADAR vs. conventional techniques for AVF maturation in patients with blood viscosity and vessel elasticity-related diseases through fluid-structure interaction modeling: Anemia, hypertension, and diabetes

“…AVF Thrombus is a significant risk factor for patients with CKD, and it is often associated with hypertension, anemia, and diabetes [ 75 ]. These diseases can impact blood vessel elasticity and affect blood flow patterns and WSS.…”

The Effectiveness of Electronic Cannulation Atlas in Patients with Arteriovenous Fistula

“…Hemodialysis patients, who were often elderly and might have underlying conditions like diabetes mellitus and hypertension, tend to have blood vessels in poor condition, making cannulation more difficult for nurses. 11 , 22 , 23 Patients’ fear of pain often hindered nurses from changing the cannulation point, thereby making it challenging to implement the rope ladder cannulation method in clinical settings. 24 Our research team utilized information technology to strategically plan and establish fixed cannulation points for patients.…”

COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review

“…This mechanism does pose an additional health burden for the haemodialysis population who are already at greater risk of thrombosis through exposure to the extracorporeal dialysis circuit. Data on whether there is a significantly increased risk of thrombosis in the elderly population compared to younger persons receiving haemodialysis remain unestablished, but numerous studies have documented catheter, circuit, and arterial venous fistula thrombosis in patients with COVID-19 infection [ 64 , 65 , 66 , 67 ]. This can lead to delays in dialysis treatment, excess blood loss and other complications which may impact upon the elderly haemodialysis population more significantly, particularly those living with multimorbidities and more severe levels of frailty [ 65 , 66 , 67 ].…”